Sono-Tek H1 Revenue Rises 6% to $10.9 Million as Medical Sales Surge
Sono-Tek Corporation (SOTK) reported revenue of $10.9 million for the first half of fiscal 2027, up 6% from the prior year. Operating income increased 41% with a gross margin of 55%. The performance was propelled by a 289% surge in medical segment sales.
The strong growth in medical sales highlights a shift toward higher-value production systems, boosting operating profitability despite timing factor risks in customer orders. Sono-Tek stock traded down 0.56% at $7.12 following the report.
Looking ahead, the company reaffirmed its fiscal 2027 outlook expecting flat to modest revenue growth. Investors will be watching how efficiently the company converts its record order backlog into recognized revenue for fiscal 2028.
Key points
- First-half fiscal 2027 revenue grew 6% to $10.9 million.
- Operating income increased 41% with a 55% gross margin.
- Medical segment sales surged 289% during the period.
- Management reaffirmed flat to modest revenue growth for fiscal 2027.
- Record orders are enhancing top-line visibility into fiscal 2028.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What were Sono-Tek's first-half fiscal 2027 results?
Sono-Tek reported first-half revenue of $10.9 million, up 6% year over year. Operating income increased 41% while gross margin reached 55%, supported by a 289% increase in medical segment sales.
What is Sono-Tek's sales guidance for fiscal 2027?
Sono-Tek reiterated its full-year fiscal 2027 guidance, expecting flat to modest revenue growth due to the timing of customer orders.
How are record orders affecting Sono-Tek's outlook for fiscal 2028?
Record order volume is providing stronger revenue visibility into fiscal 2028, setting expectations for improved future growth as orders convert into sales.